An investigation of the role of estradiol in fear reduction during a single session of exposure therapy
Hannah C. LevyJessica MullinsDavid F. Tolina Anxiety Disorders Center,Institute of Living,200 Retreat Avenue,Hartford,CT 06106,USAb Department of Obstetrics and Gynecology,Hartford Hospital,80 Seymour Street,Hartford,CT 06106,USAc Yale University School of Medicine,333 Cedar Street New,Haven,CT 06510,USA
DOI: https://doi.org/10.1080/16506073.2024.2313743
2024-02-01
Cognitive Behaviour Therapy
Abstract:Research suggests that estradiol may moderate fear extinction. It is unclear whether these results generalize to exposure therapy. The aim of the current study was to determine whether estradiol moderates outcomes in exposure therapy among women with anxiety disorders. Participants were 35 women with a primary diagnosis of an anxiety disorder who participated in the study as part of routine care at an anxiety specialty clinic. Endogenous estradiol was assessed via saliva. They provided subjective distress ratings before (pre) and after (post) an exposure session, as well as after a brief delay (recall). Contrary to predictions, there were no significant differences in exposure outcomes between the high and low estradiol groups. However, among participants with primary obsessive-compulsive disorder (OCD), results were partially consistent with the hypotheses. Women with lower estradiol initially demonstrated more improvement in subjective distress from pre- to post-exposure, but after the delay, significantly greater distress (attenuated extinction recall). Results suggest that women with lower estradiol may respond less favorably to exposure therapy for OCD relative to women with higher estradiol. These findings await replication in larger samples with longer recall delays. Should replication occur, these results may inform the use of estradiol to augment exposure therapy.
psychology, clinical